•
Jun 30, 2014

Jazz Pharmaceuticals Q2 2014 Earnings Report

Total Revenue
$291B
Previous year: $208M
+139745.0%
EPS
$0.75
Previous year: $1.43
-47.6%
Gross Profit
$261M
Previous year: $183M
+42.2%
Cash and Equivalents
$268M
Previous year: $504M
-46.8%
Total Assets
$3.16B
Previous year: $2.09B
+50.7%

Jazz Pharmaceuticals

Jazz Pharmaceuticals